Medications that target catecholamine-associated inflammation may prevent cytokine storm syndrome associated with COVID-19 and other diseases
Preventing cytokin storm syndrom in Covid 19
Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists
Published | Updated